PRIMECAP Management
PRIMECAP Management
PRIMECAP Management is tracked through public portfolio filings, disclosed holdings, and institutional investment activity. This PRIMECAP Management portfolio page tracks PRIMECAP Management holdings, stock picks, latest portfolio moves, and historical 13F filing changes so readers can see which public companies PRIMECAP Management owns and how disclosed positions change over time. PRIMECAP Management's public portfolio can help investors study position sizing, sector exposure, concentration, new buys, trims, exits, and the market themes behind reported capital allocation decisions. Top disclosed holdings and portfolio changes shown on this page include Eli Lilly and Company Common Stock (LLY), Boston Scientific Corp (BSX), Microsoft Corp (MSFT), ConocoPhillips Common Stock (COP), and Alphabet Cl A (GOOGL). Investors use PRIMECAP Management 13F filings to study portfolio concentration, new buys, trims, exits, sector exposure, and the market evidence behind the latest disclosed holdings.
Latest Portfolio Moves
| Company | Portfolio Value | Portfolio Change | Position Change | Avg Buy Price | Current Price |
|---|---|---|---|---|---|
| $8.5B9.2M shares | TrimQ1 2026 13F | $1.5B | $1,013.80 | $1,149.15 | |
| $2.0B32.5M shares | TrimQ1 2026 13F | $924M | $71.92 | $48.70 | |
| $2.7B7.3M shares | TrimQ1 2026 13F | $835M | $418.44 | $411.74 | |
| $1.5B11.6M shares | AddQ1 2026 13F | $445M | $117.69 | $118.89 | |
| $4.3B15M shares | TrimQ1 2026 13F | $425M | $314.21 | $363.31 |